These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14698705)

  • 1. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy.
    Doughty J; Baker GA; Jacoby A; Lavaud V
    Epilepsy Behav; 2003 Dec; 4(6):710-6. PubMed ID: 14698705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrono impact versus enteric coated valproate in Thai epileptic patients.
    Towanabut S; Tiemkao S; Thammasupapong S; Kijjarak R; Arayawichanon A; Poungvarin N; Sirimaharaj S; Chaisewikul R; Asawavichenjinda T; Maneesuk S; Silpakit O
    J Med Assoc Thai; 2005 Nov; 88(11):1651-9. PubMed ID: 16471115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in pharmaceutical development presentation with improved pharmacokinetics: a new formulation for valproate.
    Genton P
    Acta Neurol Scand Suppl; 2005; 182():26-32. PubMed ID: 16359430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.
    Herranz JL; Arteaga R; Adín J; Armijo JA
    Eur J Clin Pharmacol; 2006 Oct; 62(10):805-15. PubMed ID: 16896786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of 113 epileptic patients treated with sustained-release valproate.
    Despland PA
    Epilepsia; 1994; 35 Suppl 5():S99-100. PubMed ID: 8039482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old].
    Motte J; Pedespan JM; Sevestre M; Chiron C;
    Arch Pediatr; 2005 Oct; 12(10):1533-9. PubMed ID: 16099147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
    Petrukhin AS; Mukhin KIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective study comparing two formulations of valproic acid].
    Gutiérrez-Gutiérrez G; Poza-Aldea JJ; Tellería-Elmezábal J; Martí-Massó JF
    Rev Neurol; 2006 Feb 1-15; 42(3):129-32. PubMed ID: 16475132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Pylaeva OA; Petrukhin AS; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):61-5. PubMed ID: 15554145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of depakene and depakene-chrono in idiopathic generalized epilepsy].
    Perunova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(9):45-7. PubMed ID: 14571673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily monotherapy with prolonged-release valproate minitablets given in the evening--a chronopharmacological study.
    Graf W; Fraunberger B; Yang T; Kerling F; Pauli E; Stefan H
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):439-43. PubMed ID: 19640350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of epileptic seizures resistant to phenobarbital in children during the first year of life].
    Rudenko AIu; Konoplianko TV; Stetsiuk RA
    Lik Sprava; 2002; (1):52-6. PubMed ID: 11944381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-release formulations for the treatment of epilepsy.
    Bialer M
    CNS Drugs; 2007; 21(9):765-74. PubMed ID: 17696575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving beyond sodium valproate: choosing the right anti-epileptic drug in children.
    Balagura G; Iapadre G; Verrotti A; Striano P
    Expert Opin Pharmacother; 2019 Aug; 20(12):1449-1456. PubMed ID: 31099271
    [No Abstract]   [Full Text] [Related]  

  • 19. A 3 year audit of adult epilepsy care in a Nigerian tertiary hospital (2011-2013).
    Sanya EO; Wahab KW; Desalu OO; Bello HA; Ademiluyi BA; Alaofin WA; Busari K
    Ann Afr Med; 2015; 14(2):97-102. PubMed ID: 25693817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
    Kaminow L; Schimschock JR; Hammer AE; Vuong A
    Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.